These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 25238820)
21. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study. Eriksdotter M; Vedin I; Falahati F; Freund-Levi Y; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Cederholm T; Palmblad J J Alzheimers Dis; 2015; 48(3):805-12. PubMed ID: 26402079 [TBL] [Abstract][Full Text] [Related]
22. [Analysis of the Cochrane Review: Omega-3 Fatty Acids for the Treatment of Dementia. Cochrane Database Syst Rev. 2016;4:CD009002.]. Cordeiro Sousa D; Ferreira Dos Santos G; Costa J; Vaz-Carneiro A Acta Med Port; 2017 Oct; 30(10):671-674. PubMed ID: 29268059 [TBL] [Abstract][Full Text] [Related]
23. Effect of Multidomain Intervention, Omega-3 Polyunsaturated Fatty Acids Supplementation or their Combinaison on Cognitive Function in Non-Demented Older Adults According to Frail Status: Results from the MAPT Study. Tabue-Teguo M; Barreto de Souza P; Cantet C; Andrieu S; Simo N; Fougère B; Dartigues JF; Vellas B J Nutr Health Aging; 2018; 22(8):923-927. PubMed ID: 30272094 [TBL] [Abstract][Full Text] [Related]
24. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease. Wood AHR; Chappell HF; Zulyniak MA Eur J Nutr; 2022 Mar; 61(2):589-604. PubMed ID: 34392394 [TBL] [Abstract][Full Text] [Related]
25. Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials. Zhang XW; Hou WS; Li M; Tang ZY Aging Clin Exp Res; 2016 Feb; 28(1):165-6. PubMed ID: 26025463 [TBL] [Abstract][Full Text] [Related]
26. Omega 3 fatty acids and cognitive health in older people. Dangour AD; Andreeva VA; Sydenham E; Uauy R Br J Nutr; 2012 Jun; 107 Suppl 2():S152-8. PubMed ID: 22591889 [TBL] [Abstract][Full Text] [Related]
27. Effect of vitamin B12 and omega-3 fatty acid supplementation on brain neurotrophins and cognition in rats: A multigeneration study. Rathod RS; Khaire AA; Kale AA; Joshi SR Biochimie; 2016; 128-129():201-8. PubMed ID: 27569259 [TBL] [Abstract][Full Text] [Related]
28. N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology. Pusceddu MM; Kelly P; Stanton C; Cryan JF; Dinan TG Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608809 [TBL] [Abstract][Full Text] [Related]
29. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why? Das UN Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):11-9. PubMed ID: 18054217 [TBL] [Abstract][Full Text] [Related]
30. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Yurko-Mauro K Curr Alzheimer Res; 2010 May; 7(3):190-6. PubMed ID: 20088810 [TBL] [Abstract][Full Text] [Related]
31. The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review. Issa AM; Mojica WA; Morton SC; Traina S; Newberry SJ; Hilton LG; Garland RH; Maclean CH Dement Geriatr Cogn Disord; 2006; 21(2):88-96. PubMed ID: 16340205 [TBL] [Abstract][Full Text] [Related]
32. Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease. Thomas J; Thomas CJ; Radcliffe J; Itsiopoulos C Biomed Res Int; 2015; 2015():172801. PubMed ID: 26301243 [TBL] [Abstract][Full Text] [Related]
34. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Geleijnse JM; Giltay EJ; Kromhout D Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845 [TBL] [Abstract][Full Text] [Related]
35. Associations and effects of omega-3 polyunsaturated fatty acids on cognitive function and mood in healthy adults: a protocol for a systematic review of observational and interventional studies. O' Donovan F; Carney S; Kennedy J; Hayes H; Pender N; Boland F; Stanton A BMJ Open; 2019 Jun; 9(6):e027167. PubMed ID: 31230010 [TBL] [Abstract][Full Text] [Related]
36. Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature. Huang TL J Alzheimers Dis; 2010; 21(3):673-90. PubMed ID: 20634589 [TBL] [Abstract][Full Text] [Related]
37. Diet and Alzheimer's disease risk factors or prevention: the current evidence. Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488 [TBL] [Abstract][Full Text] [Related]
38. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Fotuhi M; Mohassel P; Yaffe K Nat Clin Pract Neurol; 2009 Mar; 5(3):140-52. PubMed ID: 19262590 [TBL] [Abstract][Full Text] [Related]
39. Can Curcumin Counteract Cognitive Decline? Clinical Trial Evidence and Rationale for Combining ω-3 Fatty Acids with Curcumin. Kuszewski JC; Wong RHX; Howe PRC Adv Nutr; 2018 Mar; 9(2):105-113. PubMed ID: 29659685 [TBL] [Abstract][Full Text] [Related]
40. Omega-3 fatty acids and cognitive function in women. Robinson JG; Ijioma N; Harris W Womens Health (Lond); 2010 Jan; 6(1):119-34. PubMed ID: 20088735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]